J. S. Kumar et al. / Tetrahedron Letters 51 (2010) 779–782
781
Table 1 (continued)
Entry
Aldehyde
Isonitrile
Product
Yield (%)
O
OH
H
N
NC
1f
16
17
18
2a
4p
65
68
67
H
O
O
O
O
O
OH
O
O
O
NC
H
N
2b
2c
4q
4r
H
H
H
O
O
O
S
NC
OH
H
N
O
OH
H
N
NC
19
20
21
1g
2a
2b
2c
4s
4t
75
72
78
S
S
S
O
OH
O
O
NC
H
N
H
H
S
S
O
OH
NC
H
N
4u
O
tively (Scheme 1). This class of boron compounds have extensive
applications in materials chemistry and synthetic chemistry as
excellent intermediates for Suzuki cross-coupling reactions.6 Sev-
eral of these compounds have also been found to exhibit important
antibacterial and antifungal properties.7
169.4, 152.3, 131.3, 130.8, 128.1, 122.9, 80.2, 51.1, 28.9; ESI-MS:
232 [(MÀH)+, 100%].
3. Conclusions
In conclusion, we have developed an efficient protocol for the
2.1. Representative procedure for the preparation of
hydroxyamide 4a
preparation of
a-hydroxyamides via boric acid mediated addition
of isonitriles onto aldehydes. The reaction in general provides good
yields of the products under very mild reaction conditions. We
have applied the methodology for an intramolecular version to
synthesize functionalized benzoxaboroles. Owing to the impor-
tance of hydroxyamides and benzoxaboroles as synthetic interme-
diates and also as medicinal agents, we believe that the current
methodology will find applications in organic and medicinal
chemistry.
To a stirred solution of propionaldehyde 1a (0.14 mL, 2.0 mmol)
in 2 mL DMF were added benzyl isonitrile 2a (0.24 mL, 2.0 mmol),
and boric acid (0.12 g, 2.0 mmol) and stirred overnight at room
temperature. Upon completion (TLC), the reaction mixture was
worked up with water and diethyl ether (3 Â 25 mL). The com-
bined organic layers were dried (MgSO4), concentrated in vacuo,
and purified by column chromatography (silica gel, hexane/ace-
tone, 4:1) to obtain 0.30 g (78%) of hydroxy amide 4a. 1H NMR
(500 MHz, CDCl3): 7.22–7.32 (m, 5H), 7.18 (bs, 1H), 4.47 (t,
J = 4.5 Hz, 1H), 4.42 (dd, J = 4.0, 15.0 Hz, 1H), 4.36 (dd, J = 4.0,
15.0 Hz, 1H),4.05–4.08 (m, 1H), 1.78–1.90 (m, 1H), 1,62–1.72 (m,
1H), 0.95 (t, J = 7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): 174.5,
138.2, 128.9, 127.9, 127.7, 73.2, 43.3, 28.1, 9.4; ESI-MS: 216
[(M+Na)+, 100%], 194 (M+H)+.
Acknowledgments
We thank the Departments of Chemistry and Biochemistry,
Rowan University, and University of Minnesota Duluth for the
funding. Partial support for this work was provided by research
grants from the National Institutes of Health (CA129993) (VRM)
and Whiteside Institute for Clinical Research (VRM).
2.2. Representative procedure for the preparation of
benzoxaborole 6b
References and notes
1. Boric Acid General Fact Sheet-National Pesticide Information Center: http://
To a stirred solution of boronoaldehyde 5 (0.3 g, 2.0 mmol) in
2 mL DMF was added tert-butyl isonitrile 2a (0.23 mL, 2.0 mmol),
and stirred overnight at room temperature. Upon completion
(TLC), the reaction mixture was worked up with water and ethyl
acetate (3 Â 25 mL). The combined organic layers were dried
(MgSO4), concentrated in vacuo, and purified by column chroma-
tography (silica gel, hexane/ethyl acetate, 3:1) to obtain 0.30 g
(65%) of benzoxaborole 6b. (Found: C, 61.53; H, 8.10; N, 6.02%;
C12H16BNO3 requires: C, 61.84; H, 6.92; N, 6.01%); 1H NMR
(500 MHz, DMSO-d6): 9.33 (bs, 1H), 7.67 (d, J = 7.2 Hz, 1H), 7.62
(d, J = 7.6 Hz, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.26 (t, J = 7.4 Hz, 1H),
6.52 (s, 1H), 5.27 (s, 1H), 1.21 (s, 9H); 13C NMR (125 MHz, CDCl3):
2. (a) Shteinberg, L. Y. Russ. J. Appl. Chem. 2009, 82, 613–617; (b) Kondaiah, G. C. M.;
Reddy, L. A.; Babu, K. S.; Gurav, V. M.; Huge, K. M.; Bandichhor, R.; Reddy, P. P.;
Bhattacharya, A.; Anand, R. V. Tetrahedron Lett. 2008, 49, 106–109; (c) Nath, J.;
Chaudhuri, M. K. Green Chem. 2008, 1, 223–230; (d) Tu, S.-J.; Zhu, X.-T.; Fang, F.;
Zhang, X.-J.; Zhu, S.-L.; Li, T.-J.; Shi, D.-Q.; Wang, X.-S.; Ji, S.-J. Chin. J. Chem. 2005,
23, 596–598; (e) Chaudhuri, M. K.; Hussain, S.; Kantam, M. L.; Neelima, B.
Tetrahedron Lett. 2005, 46, 8329–8331; (f) Maki, T.; Ishihara, K.; Yamamoto, H.
Org. Lett. 2005, 7, 5047–5050; (g) Stapp, P. R. J. Org. Chem. 1973, 38, 1433–1434.
3. (a) Schenck, H. A.; Lenkowski, P. W.; Mukherjee, I. C.; Kob, S. H.; Stables, J. P.;
Patel, M. K.; Brown, M. L. Bioorg. Med. Chem. 2004, 12, 979–993; (b) Kuduk, S. D.;
Chang, R. K.; DiPardo, R. M.; Di Marco, C. N.; Murphy, K. L.; Ransom, R. W.; Reiss,
D. R.; Tang, C.; Prueksaritanont, T.; Pettibone, D. J.; Bock, M. G. Bioorg. Med. Chem.
Lett. 2008, 18, 5107–5110.
4. (a) Banfi, L.; Riva, R. Org. React. 2005, 65, 1–141; (b) Domling, A.; Ugi, I. Angew.
Chem., Int. Ed. 2000, 39, 3168–3210.